Deltex Medical Group plc
Deltex Medical Group plc, together with its subsidiaries, manufactures, markets, and sells oesophageal doppler and pulse contour analysis and monitoring platform. It offers dopplink, a patient interface cable; and pressurewave, an arterial blood pressure signal under the TrueVue brand. The company also provides oesophageal doppler monitoring systems. Deltex Medical Group plc was incorporated in 2… Read more
Deltex Medical Group plc (DTXMF) - Total Assets
Latest total assets as of December 2024: $4.39 Million USD
Based on the latest financial reports, Deltex Medical Group plc (DTXMF) holds total assets worth $4.39 Million USD as of December 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Deltex Medical Group plc - Total Assets Trend (1998–2024)
This chart illustrates how Deltex Medical Group plc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Deltex Medical Group plc - Asset Composition Analysis
Current Asset Composition (December 2024)
Deltex Medical Group plc's total assets of $4.39 Million consist of 27.3% current assets and 72.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 5.5% |
| Accounts Receivable | $284.00K | 6.5% |
| Inventory | $609.00K | 13.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $66.00K | 1.5% |
Asset Composition Trend (1998–2024)
This chart illustrates how Deltex Medical Group plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Deltex Medical Group plc's current assets represent 27.3% of total assets in 2024, a decrease from 79.5% in 1998.
- Cash Position: Cash and equivalents constituted 5.5% of total assets in 2024, down from 46.4% in 1998.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 1998.
- Asset Diversification: The largest asset category is inventory at 13.9% of total assets.
Deltex Medical Group plc Competitors by Total Assets
Key competitors of Deltex Medical Group plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Deltex Medical Group plc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Deltex Medical Group plc generates 0.47x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Deltex Medical Group plc is currently not profitable relative to its asset base.
Deltex Medical Group plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.69 | 1.89 | 1.38 |
| Quick Ratio | 0.34 | 1.13 | 1.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-547.00K | $ 835.00K | $ 906.00K |
Deltex Medical Group plc - Advanced Valuation Insights
This section examines the relationship between Deltex Medical Group plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 47.99 |
| Latest Market Cap to Assets Ratio | 17.42 |
| Asset Growth Rate (YoY) | -26.1% |
| Total Assets | $4.39 Million |
| Market Capitalization | $76.40 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Deltex Medical Group plc's assets at a significant premium ( 17.42x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Deltex Medical Group plc's assets decreased by 26.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Deltex Medical Group plc (1998–2024)
The table below shows the annual total assets of Deltex Medical Group plc from 1998 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $4.39 Million | -26.06% |
| 2023-12-31 | $5.93 Million | -3.97% |
| 2022-12-31 | $6.18 Million | +14.49% |
| 2021-12-31 | $5.39 Million | -2.51% |
| 2020-12-31 | $5.53 Million | -14.80% |
| 2019-12-31 | $6.50 Million | +0.71% |
| 2018-12-31 | $6.45 Million | +9.73% |
| 2017-12-31 | $5.88 Million | -13.25% |
| 2016-12-31 | $6.78 Million | +1.04% |
| 2015-12-31 | $6.71 Million | -30.09% |
| 2014-12-31 | $9.59 Million | +24.96% |
| 2013-12-31 | $7.67 Million | +22.70% |
| 2012-12-31 | $6.25 Million | +11.20% |
| 2011-12-31 | $5.62 Million | +28.81% |
| 2010-12-31 | $4.37 Million | -12.27% |
| 2009-12-31 | $4.98 Million | +45.43% |
| 2008-12-31 | $3.42 Million | +11.57% |
| 2007-12-31 | $3.07 Million | +34.74% |
| 2006-12-31 | $2.28 Million | +3.50% |
| 2005-12-31 | $2.20 Million | -25.58% |
| 2004-12-31 | $2.96 Million | -22.39% |
| 2003-12-31 | $3.81 Million | -2.33% |
| 2002-12-31 | $3.90 Million | -45.07% |
| 2001-12-31 | $7.10 Million | +31.48% |
| 2000-12-31 | $5.40 Million | +315.07% |
| 1999-12-31 | $1.30 Million | +8.06% |
| 1998-12-31 | $1.20 Million | -- |